Neogen (NEOG) stock: analyst price target and their real reliability

Live quote · data updated Oct 14, 2026

Neogen · Health Care · ref. ETF XLV · 35 calls · price $11.73

What the company does: Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally.

📈 Neogen (NEOG) stock price

$11.73+98.5% over range

Oct 14, 25low $5.41 · high $13.98Oct 13, 26

📏 Click 2 points (left → right) to measure the change · click again to clear.

SellBuy

Buy

100% recommend buying · 2 analysts

📊 JPI status : Neogen has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 NEOG price target & analyst consensus — price $11.73

The price target · all analysts combined (2 targets)

Highest target · 2 firms of 2$14+19.4%

Median target · of 2 targets$14+19.4%

Lowest target · 2 firms of 2$14+19.4%

Current price$11.73

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Guggenheim — 69% of its targets hit on this sector (51 calls tested). It aims for $14 (+19 %), call made on October 1, 2026, maturing on October 1, 2027 (13 d ago).

The 1 reliable analyst $14+19 %

The 1 other firm $14+19 %

How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $14 median. “The 1 others” are the firms that don't pass our reliability filter on this sector.

The consensus · 2 ratings (last 6 months)

Strong Buy00%

Buy2100%

Hold00%

Sell00%

Strong Sell00%

Go deeper on the analysts

🎯 NEOG price target all

All 35 calls, one by one, with our verdict on each firm.

→ See all 35 targets, analyst by analyst

💡 The best analysts on NEOG most reliable

Their real reliability on NEOG, firm by firm: who was right, who was wrong.

→ See their reliability on NEOG

All analysts (the consensus) · vs · the best (those who've been right)

💬 A question about Neogen? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

📊 Returns & performance

🏛️ Which US Congress members hold Neogen (NEOG)?

1 Congress member has disclosed NEOG buys. Click a highlighted name to see their track record (do they beat the S&P 500?).

Greg Gianforte 1× · 44%

→ Full members ranking (who beats the market)

✅ Historical analyst reliability on NEOG

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕	% right i ↕	Gain vs sector i ↕	Calls i ↕
Guggenheim ↗	67%	+38.2%	3
Wells Fargo ↗	0%	-24.4%	2

📊 What $1,000 invested in Neogen would be worth › open the full page

In short — $1,000 invested in Neogen 10 years ago would be worth $456 today, i.e. -8%/yr on average. Best year: 2023 (+32%), worst: 2022 (-66%). Price performance, excluding dividends.

If I'd invested $1,000 in Neogen

Investment	Worth today	Gain
1 years ago	$797	-20%
3 years ago	$635	-37%
5 years ago	$244	-76%

→ See Neogen's full return history + gain calculator

Return by year (Neogen)

Year	Return	$1,000 invested at year start
2026 (YTD)	+38%	$1,383 (+38%)
2025	-42%	$797 (-20%)
2024	-40%	$481 (-52%)

→ See Neogen's full return history + gain calculator

⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Neogen

Loading news…

📋 All analyst calls on NEOG

Guggenheim ↗

Sep 30, 26

▲ Buy · 🎯$14

Price at call : $12.8 — upside +9%

Today : $11.73 — upside +19%

🎯 on NEOG : 67% (3 calls matureds) · 📊 on Health : 64.7% · +17.5% (51 calls)

in progress (365j)
matures : Sep 30, 27

Piper Sandler ↗

Aug 26, 26

▲ Overweight · 🎯$14

Price at call : $11.74 — upside +19%

Today : $11.73 — upside +19%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Aug 26, 27

Piper Sandler ↗

Aug 3, 26

■ Neutral neutral · not a buy · 🎯$13

Price at call : $11.81 — gap to target +10%

Today : $11.73 — gap to target +11%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Aug 3, 27

Piper Sandler ↗

Jan 12, 26

■ Neutral neutral · not a buy · 🎯$10

Price at call : $9.19 — gap to target +9%

Today : $11.73 — gap to target -15%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Jan 12, 27

Guggenheim ↗

Jan 9, 26

▲ Buy · 🎯$12

Price at call : $9.37 — upside +28%

Today : $11.73 — upside +2%

🎯 on NEOG : 67% (3 calls matureds) · 📊 on Health : 64.7% · +17.5% (51 calls)

in progress (365j)
matures : Jan 9, 27

CJS Securities

Dec 10, 25

▲ Market Outperform · 🎯$10

Price at call : $7.04 — upside +42%

Today : $11.73 — upside -15%

🎯 on NEOG : no call matured yet · 📊 on Health : 50% · +29.5% (6 calls)

in progress (365j)
matures : Dec 10, 26

Piper Sandler ↗

Oct 16, 25

■ Neutral neutral · not a buy · 🎯$6.5

Price at call : $5.88 — gap to target +11%

Today : $11.73 — gap to target -45%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Oct 16, 26

CJS Securities

Sep 29, 25

■ Market Perform neutral · not a buy · 🎯$10

Price at call : $5.71 — gap to target +75%

Today : $11.73 — gap to target -15%

🎯 on NEOG : no call matured yet · 📊 on Health : 50% · +29.5% (6 calls)

in progress (365j)
matures : Sep 29, 26

See the other 27 calls, newest to oldest

William Blair ↗

Jul 29, 25

■ Market Perform neutral · not a buy

🎯 on NEOG : 100% (1 call matured) · 📊 on Health : 32% · -10.8% (25 calls)

in progress (365j)
matures : Jul 29, 26

Guggenheim ↗

Jun 30, 25

▲ Buy · 🎯$10

Price at call : $4.78 — upside +109%

Today : $11.73 — upside -15%

Expected +109% · Actual +88% · Reason (≥ +15%) : ✓ Yes

🎯 on NEOG : 67% (3 calls matureds) · 📊 on Health : 64.7% · +17.5% (51 calls)

+88.1%

stock +88% · XLV +18%

matured Jun 30, 26

Piper Sandler ↗

Apr 22, 25

■ Neutral neutral · not a buy · 🎯$5

Price at call : $4.92 — gap to target +2%

Today : $11.73 — gap to target -57%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Apr 22, 26

Piper Sandler ↗

Apr 14, 25

■ Neutral neutral · not a buy · 🎯$6.5

Price at call : $5.4 — gap to target +20%

Today : $11.73 — gap to target -45%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Apr 14, 26

Guggenheim ↗

Apr 10, 25

▲ Buy · 🎯$13

Price at call : $5.63 — upside +131%

Today : $11.73 — upside +11%

Expected +131% · Actual +67% · Reason (≥ +15%) : ✓ Yes

🎯 on NEOG : 67% (3 calls matureds) · 📊 on Health : 64.7% · +17.5% (51 calls)

+67.3%

stock +67% · XLV +9%

matured Apr 10, 26

Piper Sandler ↗

Jan 21, 25

■ Neutral neutral · not a buy · 🎯$13

Price at call : $11.95 — gap to target +9%

Today : $11.73 — gap to target +11%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Jan 21, 26

Guggenheim ↗

Dec 19, 24

▲ Buy · 🎯$15

Price at call : $12.04 — upside +25%

Today : $11.73 — upside +28%

Expected +25% · Actual -41% · Reason (≥ +15%) : ✗ No

🎯 on NEOG : 67% (3 calls matureds) · 📊 on Health : 64.7% · +17.5% (51 calls)

-40.8%

stock -41% · XLV +13%

matured Dec 19, 25

Piper Sandler ↗

Aug 6, 24

■ Neutral neutral · not a buy · 🎯$17.5

Price at call : $16.75 — gap to target +4%

Today : $11.73 — gap to target +49%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Aug 6, 25

Piper Sandler ↗

Apr 15, 24

■ Neutral neutral · not a buy · 🎯$17

Price at call : $12.16 — gap to target +40%

Today : $11.73 — gap to target +45%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Apr 15, 25

Piper Sandler ↗

Jan 18, 24

■ Neutral neutral · not a buy · 🎯$19

Price at call : $17 — gap to target +12%

Today : $11.73 — gap to target +62%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Jan 17, 25

Piper Sandler ↗

Oct 16, 23

■ Neutral neutral · not a buy · 🎯$17.5

Price at call : $15.15 — gap to target +16%

Today : $11.73 — gap to target +49%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Oct 15, 24

Wells Fargo ↗

Aug 14, 23

▲ Overweight · 🎯$28

Price at call : $23.61 — upside +19%

Today : $11.73 — upside +139%

Expected +19% · Actual -30% · Reason (≥ +15%) : ✗ No

🎯 on NEOG : 0% (2 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)

-29.6%

stock -30% · XLV +11%

matured Aug 13, 24

Wells Fargo ↗

Jun 16, 23

▲ Overweight · 🎯$22

Price at call : $20.77 — upside +6%

Today : $11.73 — upside +88%

Expected +6% · Actual -19% · Reason (≥ +15%) : ✗ No

🎯 on NEOG : 0% (2 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)

-19.3%

stock -19% · XLV +10%

matured Jun 15, 24

Piper Sandler ↗

Dec 15, 22

■ Neutral neutral · not a buy · 🎯$17

Price at call : $15.13 — gap to target +12%

Today : $11.73 — gap to target +45%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Dec 15, 23

William Blair ↗

Nov 22, 22

▲ Outperform

Actual +5% · Reason (≥ +15%) : ✗ No

🎯 on NEOG : 100% (1 call matured) · 📊 on Health : 32% · -10.8% (25 calls)

+5.1%

stock +5% · XLV -4%

matured Nov 22, 23

Piper Sandler ↗

Oct 10, 22

■ Neutral neutral · not a buy · 🎯$14

Price at call : $11.68 — gap to target +20%

Today : $11.73 — gap to target +19%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Oct 10, 23

Piper Sandler ↗

Aug 30, 22

■ Neutral neutral · not a buy · 🎯$20

Price at call : $21.17 — gap to target -6%

Today : $11.73 — gap to target +71%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Aug 30, 23

Piper Sandler ↗

Aug 1, 22

■ Neutral neutral · not a buy · 🎯$26

Price at call : $22.58 — gap to target +15%

Today : $11.73 — gap to target +122%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Aug 1, 23

Piper Sandler ↗

Jul 12, 22

■ Neutral neutral · not a buy · 🎯$25

Price at call : $22.66 — gap to target +10%

Today : $11.73 — gap to target +113%

🎯 on NEOG : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)

in progress (365j)
matures : Jul 12, 23

Craig-Hallum ↗

Mar 19, 19

▲ Buy

Actual -16% · Reason (≥ +15%) : ✗ No

🎯 on NEOG : 0% (1 call matured) · 📊 on Health : 52% · +14.5% (25 calls)

-15.6%

stock -16% · XLV -9%

matured Mar 18, 20

Stephens & Co. ↗

Mar 27, 18

■ Equal-Weight neutral · not a buy · 🎯$32.5

Price at call : $32.8 — gap to target -1%

Today : $11.73 — gap to target +177%

🎯 on NEOG : no call matured yet · 📊 on Health : 44.3% · +2.1% (88 calls)

in progress (365j)
matures : Mar 27, 19

CL King

Jul 14, 17

■ Neutral neutral · not a buy

🎯 on NEOG : no call matured yet · 📊 unranked overall

in progress (365j)
matures : Jul 14, 18

Craig-Hallum ↗

Dec 22, 15

■ Hold neutral · not a buy

🎯 on NEOG : 0% (1 call matured) · 📊 on Health : 52% · +14.5% (25 calls)

in progress (365j)
matures : Dec 21, 16

Stephens & Co. ↗

Mar 17, 15

■ Equal-Weight neutral · not a buy

🎯 on NEOG : no call matured yet · 📊 on Health : 44.3% · +2.1% (88 calls)

in progress (365j)
matures : Mar 16, 16

Cowen & Co.

Aug 11, 14

■ neutral · not a buy · 🎯$14.6287

Price at call : $16.82 — gap to target -13%

Today : $11.73 — gap to target +25%

🎯 on NEOG : no call matured yet · 📊 unranked overall

in progress (365j)
matures : Aug 11, 15

Janney Montgomery Scott

Aug 15, 13

■ Neutral neutral · not a buy · 🎯$15.2538

Price at call : $14.08 — gap to target +8%

Today : $11.73 — gap to target +30%

🎯 on NEOG : no call matured yet · 📊 on Health : 61.5% · +15.3% (13 calls)

in progress (365j)
matures : Aug 15, 14

Wellington Shields

Jul 24, 13

■ Trading Sell neutral · not a buy

🎯 on NEOG : no call matured yet · 📊 unranked overall

in progress (365j)
matures : Jul 24, 14

Frequently asked questions

Should I buy Neogen stock?

This isn't buy advice. For Neogen, the analyst consensus is "Buy", with an average price target of $14.00 (+19% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 67% of the time (3 calls tracked on Neogen). We show the numbers — you decide.

Is it too late to buy Neogen? How high can it go?

The most bullish analyst target on Neogen is $14.00 (+19% above today's price); the average is $14.00. That's the upside they see. Check how reliable those analysts have actually been on Neogen on our site before trusting it.

Is Neogen still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 2 analysts have a real record on Neogen, the best hitting 67% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.

What has Neogen's past performance been?

Historical returns and a "how much if I had invested" calculator: NEOG performance & returns.